NCT03272269 - Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 23, 2017

Primary Completion Date

April 17, 2019

Study Completion Date

August 30, 2019

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

IMCY-0098

Small synthetic peptide for SC admin. Solvent: alum hydroxide

OTHER

Placebo

Solvent: alum hydroxide

Trial Locations (17)

Hôpital Erasme, Brussels

UZ Brussel, Brussels

UZ Gent, Ghent

Bispebjerg and Frederiksberg Hospital, Copenhagen

CHU de Nantes, Hôpital Laennec, Nantes

GWT-TUD GmbH, Dresden

Klaipeda University Hospital, Klaipėda

University Hospital Santaros Klinikos, Vilnius

Clinical Trial Center, CTC, Gothenburg

ProbarE Stockholm, Stockholm

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Cardiff University, Cardiff

Royal Devon and Exeter NHS Trust, Exeter

Guy's and St. Thomas NHS Trust, London

St. Bartholomew's Hospital (Barts Health NHS Trust), London

Newcastle University, Newcastle upon Tyne

Oxford University Hospitals NHS Foundation Trust, Oxford